Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review voucher
Biotech
Stealth CEO questions FDA rejection of rare disease drug
“We are kind of hanging on by our fingernails here to try to bring this drug to the patient community,” Stealth CEO Reenie McCarthy told Fierce Biotech.
Gabrielle Masson
May 29, 2025 2:27pm
PTC sells priority review voucher from Kebilidi nod for $150M
Nov 27, 2024 8:35am
Acadia makes $100M profit from $150M pediatric voucher sale
Nov 6, 2024 9:36am
Valneva sells priority review voucher for $103M, R&D to benefit
Feb 5, 2024 9:15am
Novartis buys priority review voucher from Pharming for $21M
Jun 1, 2023 7:12am
Marinus sells priority review voucher to Novo Nordisk for $110M
Jul 14, 2022 10:50am
